Leslie Citrome, MD | Psychiatrist.com

Original Research

Lemborexant NNT, NNH, and LHH for Treatment of Insomnia

June 1, 2021

Many pharmacologic treatment options are available for insomnia. In this study, the clinical utility of the new hypnotic lemborexant is given clinical perspective via the evidence-based medicine tools of...

Leslie Citrome, Timothy Juday, Feride Frech, et al

Original Research

Asenapine Transdermal System for Schizophrenia

December 15, 2020

Transdermal asenapine administration may address unmet needs in patients with schizophrenia, including improved adherence. This phase 3 study assessed efficacy and safety of HP-3070, an asenapine transdermal system (patch),...

Leslie Citrome, David P. Walling, Courtney M. Zeni, et al

Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al

Original Research

Olanzapine Plus Samidorphan in Schizophrenia With AUD

March 10, 2020

Alcohol use disorder is comorbid in 33% of US patients with schizophrenia. Testing the tolerability of olanzapine and samidorphan until the first event of exacerbation of disease symptoms is...

Mary F. Brunette, Christoph U. Correll, Stephanie S. O' Malley, et al

Consensus Statement

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.

Stanley N. Caroff, Leslie Citrome, Jonathan Meyer, et al

ASCP Corner

Inaccurate Prescribing Warnings in EMR Systems: A Survey

December 4, 2019

Are electronic prescribing alerts useful or simply annoying? A survey gathered the opinions of ASCP members on several aspects of these alerts, including how often they are inaccurate and...

Katharine A. Phillips, Leslie Citrome

Educational Activity

Integrating Novel Antidepressants in MDD Treatment

July 30, 2019

New mechanisms of action present new opportunities to improve outcomes for patients with depression. Listen to a panel of experts discuss best practices and novel antidepressants at the 2019...

Leslie Citrome, Bradley N. Gaynes, Joseph F. Goldberg, et al

Review Article

Transdermal Treatments in Psychiatry

July 16, 2019

Transdermal delivery is an alternative to oral routes of drug administration. This delivery route has several innate advantages that may benefit patients with CNS disorders—read this Expert Commentary to...

Leslie Citrome, Courtney M. Zeni, Christoph U. Correll

Letter to the Editor

Dr Correll and Colleagues Reply

October 25, 2017

Christoph U. Correll, Leslie Citrome, Peter M. Haddad, et al

Letter to the Editor

Sensitive and Personalized Determinations of Likelihood of Being Helped or Harmed

May 24, 2017

Terence A. Ketter, Leslie Citrome

Supplement Article

Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment

January 25, 2017

Leslie Citrome

Original Research

Lurasidone in Early Nonresponding Schizophrenia

December 28, 2016

What's the next step when a patient doesn' t respond to an antipsychotic? Should you augment, switch medications, wait and see, or raise the dose? Read this study in...

Antony Loebel, Robert Silva, Robert Goldman, et al

« 1 2 3 4 5 »